This Investor Still Bets on Energy, Biotech Heading Into Q4
Most U.S.
Posts Tagged ‘NASDAQ:GILD’
What Did We Learn from Billionaire Cliff Asness’ Presentation at the Bloomberg Summit?
As the hedge fund manager of AQR Capital Management, a quant fund that runs a $50.44 billion equity portfolio, billionaire Cliff Asness is content with some ambiguity. At the...
5 Best Stocks To Buy According To 4 Billionaire Quants
What are the best stocks to buy? The Wisdom of Crowds: Why the Many Are Smarter Than The Few and How Collective Wisdom Shapes Business, Economies, Societies and Nations is James...
McKinley Capital Management’s Top Picks Include Apple Inc (AAPL), Facebook Inc (FB) & Gilead Sciences Inc (GILD)
McKinley Capital Management, headed by Robert B.
Columbus Circle Investors Reduces Holdings in Its 3 Top Stock Picks of Q2
Columbus Circle Investors is a Connecticut-based growth focused hedge fund and asset manager established by Donald Chiboucis in 1975.
This Healthcare Fund Thinks Large-Caps Are The Best Way To Go
HealthInvest Partners AB, led by Anders Hallberg and Carl Bennet, was founded back in 2006 with the purpose of investing in healthcare companies that are leaders in their market...
11 Biggest Generic Drug Companies in the World
When it comes to 11 Biggest Generic Drug Companies in the World one can say that the list hasn’t changed a great deal over the years.
Five Best Stocks to Buy According To Quant Billionaires
One of the best ways to pick high-performing stocks is to follow the industry leaders and find out their stock investments.
Matthew Tewksbury Unlocked Joel Greenblatt’s Magic Formula
After an analysis of the portfolio of Matthew Tewksbury’s Stevens Capital Management, it is highly likely that the investment manager has unlocked the Magic Formula investment...
Billionaire Cooperman Isn’t Gambling With These Stocks Anymore
Leon Cooperman’s Omega Advisors recently filed a 13G with the SEC, reporting the sale of its stake in Caesars Entertainment Corp (NASDAQ:CZR).
5 Most Popular Healthcare Stocks Among Hedge Funds
According to a recent study by CIT, a reputable firm that is involved in financing and advisory services to the healthcare sector, healthcare executives seem rather optimistic...
Gilead Sciences Inc. (GILD), Yahoo! Inc. (YHOO) and Sinclair Broadcast Group Inc. (SBGI) Among the Top Picks of Bernard Selz
Selz Capital LCC is a New York-based hedge fund firm that currently manages an equity portfolio worth $580 million.
David Lamond’s Top Healthcare and Technology Stock Picks
Founded in 2011, David Lamond's Lamond Capital Partners filed its first 13F form in 2012, when it held nearly $110 million in assets under management.
Apple Inc. (AAPL), Gilead Sciences (GILD) & Facebook Inc (FB): Among Top Picks of Columbus Circle Investors
Donald Chiboucis’ Columbus Circle Investors is a hedge fund established in 1975 and currently holds around $16 billion in Assets Under Management.
Selz Capital’s Latest 13F Reveals New Position in Yahoo! Inc. (YHOO) & Bets on Industrials and Healthcare
Selz Capital LLC is a hedge fund headquartered in New York and managed by Bernard T. Selz since 2003.
Krishen Sud’s Sivik Global Loves These Healthcare Stocks
Krishen Sud’s Sivik Global Healthcare has filed its latest 13F with the SEC, disclosing the holdings in its equity portfolio as of March 31.
Billionaire Ray Dalio’s Top Picks Outshined By His Fund’s Performance
Ray Dalio's Bridgewater Associates might not have fared so well in terms of its long equity positions, which returned 0.6% in the first quarter according to our returns metric...
Joel Greenblatt’s Magic Formula Worked During Q1 But Top Picks Undeperformed Mr. Market
As the first quarter of 2015 has finished we are able to provide you with relevant analysis reflecting the institutional investors’ equity portfolios returns based on the 13F...
Apple Inc. (NASDAQ:AAPL), Facebook Inc (NASDAQ:FB): What Stocks Julian Robertson Likes and His Take on Market Bubbles
Billionaire Julian Robertson is a hedge fund legend and his opinion is highly valued on the Street, which is one of the reasons why we follow Tiger Management and analyze its ...
Actavis plc (ACT), Valeant Pharmaceuticals Intl Inc (VRX) & More: Top Healthcare Picks Among Hedge Funds Crushed Mr. Market
The first quarter of 2015 is over and before hedge funds start releasing their Form 13F filings over the next 45 days, we will take a look at the performance of the stocks they...
Ray Dalio and Billionaires Are Crazy About These Stocks
Ray Dalio's Bridgewater Associates, which is one of the world's largest hedge funds, revealed its equity portfolio in a filing with SEC.
Billionaire Julian Robertson’s Long Term Stock Picks
Billionaire Julian Robertson‘s hedge fund Tiger Management, disclosed an equity portfolio valued at some $509.8 million as of the end of 2014.
Gilead Sciences (GILD), AstraZeneca (AZN), Bellicum Pharmaceuticals (BLCM): Redmile Group’s Top New Picks
Jeremy Green’s Redmile Group entered several new positions last quarter, as revealed by the 13F Form it filed with the U.S. Securities and Exchange Commission in February.
Mallinckrodt PLC (MNK), Pfizer Inc. (PFE): Healthcor Management’s Top 5 Health Stocks
Arthur B. Cohen and Joseph Healey’s Healthcor Management LP recently filed its latest 13F with the SEC, disclosing its equity positions at the end of 2014.
Allergan, Inc. (AGN), HCA Holdings Inc (HCA), Gilead Sciences, Inc. (GILD) Among Healthcare Stocks That Billionaires Love
The healthcare sector is one that has been performing very well in the short, but also medium and long-term.
Gilead Sciences, Inc., Amgen, Inc., Biogen Idec Inc Among Billionaires’ 5 Hottest Biotech Picks
With the high volatility prevalent in the biotechnology sector, investors have a hard time picking the right stocks to invest in.
10 Most Popular Healthcare Stocks Among Hedge Funds
With the business of analyzing and compiling the data of our 737 tracked hedge funds’ latest 13F filings behind us, we’re ready to start sharing some of the findings from ...
Billionaire Julian Robertson’s Top Picks and a Put: Alibaba Group Holding Ltd (BABA), Amazon.com, Inc. (AMZN), Netflix, Inc. (NFLX), and Gilead Sciences, Inc. (GILD)
Julian Robertson's Tiger Management has considerably increased the market value of its portfolio during the last quarter (nearly 35%).
Apple Inc. (AAPL), Microsoft Corporation (MSFT), and Intel Corporation (INTC): Bridgewater Associates Reveals Top Picks
Ray Dalio’s Bridgewater Associates revealed its top picks for the fourth quarter in a 13F Form filed with the U.S. Securities and Exchange Commission.
Express Scripts Holding Company (ESRX) Shuts Out Gilead Sciences Inc. (GILD) On A Cheaper Hepatitis C Treatment
Express Scripts Holding Company (NASDAQ:ESRX) desire to accord Hepatitis C patients with what it believes to be the best of care has seen it ink a discounted deal with AbbVie...
Gilead Sciences Inc (GILD) And Merck & Co Inc (MRK) Fighting For 3 Billion-Per-Quarter Profits
Gilead Sciences, Inc. (NASDAQ:GILD), AbbVie Inc (NYSE:ABBV) and Merck & Co., Inc. (NYSE:MRK) have participated at the liver meeting in Boston, Massachusetts.
Gilead Sciences, Inc. (GILD): Bears Are Not Going to Get Honeywell International Inc. (HON) Soon
Saira Malik of TIAA-CREF stated on CNBC that is time to change their portfolio, so Gilead Sciences, Inc. (NASDAQ:GILD) is shorted and Honeywell International Inc.
NASH a Big Opportunity For Gilead Sciences, Inc. (GILD)
After being a dominant player in the hepatitis C market with its drug Sovaldi, Gilead Sciences, Inc.
Actavis plc (ACT), Gilead Sciences Inc. (GILD), Macquaire Infrastructure Company LLC (MIC): Selz Capital’s Top Stock Positions for Q2 2014
Bernard Selz’s Selz Capital recently disclosed at the SEC its long equity positions as of June 30 2014.
David Kim’s Ghost Tree Capital Loves These Healthcare Stocks
Ghost Tree Capital is a healthcare-oriented hedge fund headquartered in New York.
Stuart Weisbrod’s Iguana Healthcare Management Is Fond of These Stocks
New York City-based Iguana Healthcare Management was founded by Stuart Weisbrod in 2010.
Rock Springs Capital Management’s Top 5 Largest Stock Picks
Rock Springs Capital Management is a Baltimore-based hedge fund founded in February 2013 by Kris Jenner. Prior to that, Jenner had spent 14 years working at T.
Billionaire Julian Robertson’s Top Stock Picks: Himax Technologies, Inc. (ADR) (HIMX), Valero Energy Corporation (VLO) & Others
In the latest 13F filing, Julian Robertson's Tiger Management has disclosed its holdings as held at the end of the fourth quarter of 2013.
4 Health-Care Industry Predictions for the Next 20 Years
It's really amazing to think about how far we've come over even the past decade in the health-care arena.
Vertex Pharmaceuticals Incorporated (VRTX), Merck & Co., Inc. (MRK), Rockwell Medical Inc (RMTI): Three Drug Classes That May Become Obsolete Within Three Years
There are few, if any, businesses in the world where innovation isn't the top priority.
Gilead Sciences, Inc. (GILD), Merck & Co., Inc. (MRK): Everyone Wants a Piece of This Mega-Blockbuster
According to a recent Bloomberg report, Gilead Sciences, Inc.
Gilead Sciences, Inc. (GILD), Vanguard Health Care ETF (VHT): How to Invest in Health Care
Sector exchange-traded funds, or ETFs, allow nervous investors to sample from the fast-paced health care industry with lessened risk.
Sanofi SA (ADR) (SNY), Bristol Myers Squibb Co. (BMY): Why Peregrine Pharmaceuticals (PPHM) Earnings Won’t Show Profits
Peregrine Pharmaceuticals (NASDAQ:PPHM) will release its latest quarterly report on Monday, and investors are under no illusions that the company will avoid losing money again...
Pfizer Inc. (PFE), GlaxoSmithKline plc (ADR) (GSK): Can This HIV Drug Challenge Gilead Sciences, Inc. (GILD)’s Domination?
ViiV Healthcare -- a joint venture by Pfizer Inc.
Vertex Pharmaceuticals Incorporated (VRTX), Merck & Co., Inc. (MRK): Gilead Sciences, Inc. (GILD) Races Against Competitors for an Oral Hepatitis-C Cure
One of the company's ushering in the next generation of hepatitis-C treatment is Gilead Sciences, Inc. (NASDAQ:GILD).
Celgene Corporation (CELG), Cytokinetics, Inc. (CYTK), Astex Pharmaceuticals, Inc. (ASTX): Is the Biotech Bubble About to Burst?
"Bubble" can be a provocative word in investing circles. Think of all that comes to mind when you hear it -- perhaps other words like over-hyped, overvalued, risky, etc.
Pfizer Inc. (PFE), Gilead Sciences, Inc. (GILD), Merck & Co., Inc. (MRK) Among Hedge Funds’ Favorite Pharma Stocks
We maintain a database of quarterly 13F filings from hundreds of hedge funds and other notable investors.
Hedge Funds Are Buying Amgen, Inc. (AMGN)
To the average investor, there are tons of metrics shareholders can use to analyze stocks. Some of the most innovative are hedge fund and insider trading activity.
Celsion Corporation (CLSN), Idenix Pharmaceuticals Inc (IDIX), GTx, Inc. (GTXI): Three Biotech Stocks That May Go to Zero
The biotech industry is a marvel among traders and investors because it can double your investment, or halve it, based on a single clinical study.
This Biogen Idec Inc. (BIIB) Data is Screaming ‘Buy, Buy, Buy’
To many market players, hedge funds are assumed to be overrated, old investment vehicles of a forgotten age.
